These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Younossi ZM; Gorreta F; Ong JP; Schlauch K; Del Giacco L; Elariny H; Van Meter A; Younoszai A; Goodman Z; Baranova A; Christensen A; Grant G; Chandhoke V Liver Int; 2005 Aug; 25(4):760-71. PubMed ID: 15998427 [TBL] [Abstract][Full Text] [Related]
8. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618 [TBL] [Abstract][Full Text] [Related]
9. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910 [TBL] [Abstract][Full Text] [Related]
10. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. McCullough AJ Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061 [TBL] [Abstract][Full Text] [Related]
11. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C. Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216 [TBL] [Abstract][Full Text] [Related]
12. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of nonalcoholic steatohepatitis (NASH). Ma X; Li Z Chin J Dig Dis; 2006; 7(1):7-11. PubMed ID: 16412031 [TBL] [Abstract][Full Text] [Related]
14. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. Komatsu M; Yazaki M; Tanaka N; Sano K; Hashimoto E; Takei Y; Song YZ; Tanaka E; Kiyosawa K; Saheki T; Aoyama T; Kobayashi K J Hepatol; 2008 Nov; 49(5):810-20. PubMed ID: 18620775 [TBL] [Abstract][Full Text] [Related]
16. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis. Sharma MR; Polavarapu R; Roseman D; Patel V; Eaton E; Kishor PB; Nanji AA Exp Mol Pathol; 2006 Dec; 81(3):202-10. PubMed ID: 16949573 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397 [TBL] [Abstract][Full Text] [Related]
19. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697 [TBL] [Abstract][Full Text] [Related]
20. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]